Marc N. Casper - 03 Sep 2024 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Issuer symbol
TMO
Transactions as of
03 Sep 2024
Net transactions value
-$7,955,374
Form type
4
Filing time
05 Sep 2024, 16:22:37 UTC
Previous filing
29 Aug 2024
Next filing
30 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $2,106,800 +10,000 +8.3% $210.68 131,192 03 Sep 2024 Direct
transaction TMO Common Stock Sale $624,929 -1,034 -0.79% $604.38 130,158 03 Sep 2024 Direct F1, F2
transaction TMO Common Stock Sale $1,330,701 -2,197 -1.7% $605.69 127,961 03 Sep 2024 Direct F1, F3
transaction TMO Common Stock Sale $378,369 -624 -0.49% $606.36 127,337 03 Sep 2024 Direct F1, F4
transaction TMO Common Stock Sale $842,439 -1,386 -1.1% $607.82 125,951 03 Sep 2024 Direct F1, F5
transaction TMO Common Stock Sale $243,564 -400 -0.32% $608.91 125,551 03 Sep 2024 Direct F1, F6
transaction TMO Common Stock Sale $244,028 -400 -0.32% $610.07 125,151 03 Sep 2024 Direct F1, F7
transaction TMO Common Stock Sale $738,076 -1,208 -0.97% $610.99 123,943 03 Sep 2024 Direct F1, F8
transaction TMO Common Stock Sale $1,012,943 -1,655 -1.3% $612.05 122,288 03 Sep 2024 Direct F1, F9
transaction TMO Common Stock Sale $426,599 -696 -0.57% $612.93 121,592 03 Sep 2024 Direct F1, F10
transaction TMO Common Stock Sale $122,796 -200 -0.16% $613.98 121,392 03 Sep 2024 Direct F1, F11
transaction TMO Common Stock Sale $123,002 -200 -0.16% $615.01 121,192 03 Sep 2024 Direct F1, F12
transaction TMO Common Stock Options Exercise $2,106,800 +10,000 +8.3% $210.68 131,192 04 Sep 2024 Direct
transaction TMO Common Stock Sale $87,025 -144 -0.11% $604.34 131,048 04 Sep 2024 Direct F1, F13
transaction TMO Common Stock Sale $1,142,465 -1,887 -1.4% $605.44 129,161 04 Sep 2024 Direct F1, F14
transaction TMO Common Stock Sale $1,028,478 -1,694 -1.3% $607.13 127,467 04 Sep 2024 Direct F1, F15
transaction TMO Common Stock Sale $1,154,383 -1,899 -1.5% $607.89 125,568 04 Sep 2024 Direct F1, F16
transaction TMO Common Stock Sale $1,492,785 -2,450 -2% $609.30 123,118 04 Sep 2024 Direct F1, F17
transaction TMO Common Stock Sale $865,349 -1,418 -1.2% $610.26 121,700 04 Sep 2024 Direct F1, F18
transaction TMO Common Stock Sale $94,877 -155 -0.13% $612.11 121,545 04 Sep 2024 Direct F1, F19
transaction TMO Common Stock Sale $216,167 -353 -0.29% $612.37 121,192 04 Sep 2024 Direct F1, F20
holding TMO Common Stock 11,300 03 Sep 2024 By Alison Casper 2020 Irrevocable Trust F21
holding TMO Common Stock 43,608 03 Sep 2024 By Floral Park Associates, Inc.
holding TMO Common Stock 5,000 03 Sep 2024 By MNC 2020 Irrevocable Trust F22

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10,000 -15% $0.000000 55,850 03 Sep 2024 Common Stock 10,000 $210.68 Direct F23
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10,000 -18% $0.000000 45,850 04 Sep 2024 Common Stock 10,000 $210.68 Direct F23
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $604.02 to $604.72, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), and (20) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.12 to $606.07, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.17 to $606.61, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.29 to $608.20, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $608.46 to $609.30, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $609.60 to $610.54, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $610.61 to $611.40, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $611.69 to $612.50, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.77 to $613.09, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $613.97 to $613.98, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $615.00 to $615.01, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $603.99 to $604.495, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.10 to $605.78, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.56 to $607.54, inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.60 to $608.37, inclusive.
F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $608.97 to $609.62, inclusive.
F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $609.99 to $610.70, inclusive.
F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $611.30 to $612.29, inclusive.
F20 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.31 to $612.48, inclusive.
F21 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F22 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F23 The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.